KCI USA, Inc., a prominent player in the medical technology industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1989, the company has established itself as a leader in advanced wound care and regenerative medicine, focusing on innovative solutions that enhance patient outcomes. KCI USA is renowned for its core products, including negative pressure wound therapy (NPWT) systems and advanced wound dressings, which are distinguished by their effectiveness and ease of use. The company has achieved significant milestones, including numerous patents and recognitions for its contributions to healthcare. With a strong market position, KCI USA continues to drive advancements in wound management, making it a trusted partner for healthcare professionals worldwide. Its commitment to quality and innovation has solidified its reputation as a key player in the medical device sector.
How does KCI USA, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
KCI USA, Inc.'s score of 18 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
KCI USA, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Solventum Corporation, which may influence its climate commitments and reporting practices. While KCI USA, Inc. has not established its own reduction targets or specific climate pledges, it is important to note that any potential targets or initiatives may be inherited from its parent company, Solventum Corporation. This relationship suggests that KCI USA, Inc. could align with broader sustainability goals set by Solventum Corporation, although specific details on these initiatives are not provided. As a subsidiary, KCI USA, Inc. may benefit from the climate strategies and performance metrics of Solventum Corporation, which could include industry-standard practices for reducing carbon emissions. However, without explicit data or commitments from KCI USA, Inc., the specifics of its climate strategy remain unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 157,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 111,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 2,229,960,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
KCI USA, Inc.'s Scope 3 emissions, which increased by 9% last year and decreased by approximately 23% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 63% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
KCI USA, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.